[Skip to Navigation]
Sign In

May 2022, Vol 158, No. 5, Pages 478-590

Editorial

Melanoma Screening—Intuition and Hope Are Not Enough

Abstract Full Text
JAMA Dermatol. 2022;158(5):483-485. doi:10.1001/jamadermatol.2022.0082

To Improve Melanoma Outcomes, Focus on Risk Stratification, Not Overdiagnosis

Abstract Full Text
JAMA Dermatol. 2022;158(5):485-487. doi:10.1001/jamadermatol.2022.0097

JAMA Dermatology—The Year in Review, 2021

Abstract Full Text
free access
JAMA Dermatol. 2022;158(5):487-489. doi:10.1001/jamadermatol.2022.0110

Melanoma Epidemiology—Pivoting to Low- and Middle-Income Countries

Abstract Full Text
JAMA Dermatol. 2022;158(5):489-491. doi:10.1001/jamadermatol.2022.0162

A Tribute to Constance Maria Murphy

Abstract Full Text
free access
JAMA Dermatol. 2022;158(5):492. doi:10.1001/jamadermatol.2022.0400
Original Investigation

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040

Abstract Full Text
JAMA Dermatol. 2022;158(5):495-503. doi:10.1001/jamadermatol.2022.0160

This epidemiological assessment uses the GLOBOCAN database to evaluate the numbers of new cases and deaths due to cutaneous melanoma globally and by world region in 2020 and to estimate global values in 2040.

Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System

Abstract Full Text
has audio
JAMA Dermatol. 2022;158(5):504-512. doi:10.1001/jamadermatol.2022.0253

This quality improvement study compares thickness-specific incidence of melanoma in screened vs unscreened patients following the initiation of a primary care–based skin cancer screening initiative.

Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database

Abstract Full Text
JAMA Dermatol. 2022;158(5):513-522. doi:10.1001/jamadermatol.2022.0364

This cohort study estimates the persistence of first-line biologics and compares this persistence among different therapeutic classes in a large national cohort of patients with psoriasis and psoriatic arthritis.

Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis

Abstract Full Text
open access
JAMA Dermatol. 2022;158(5):523-532. doi:10.1001/jamadermatol.2022.0455

This living systematic review and network meta-analysis examines the association of systemic treatments for atopic dermatitis with scores on the Eczema Area and Severity Index, Patient Oriented Eczema Measure, Dermatology Life Quality Index, and Peak Pruritus Numeric Rating Scales.

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial

Abstract Full Text
open access
JAMA Dermatol. 2022;158(5):533-541. doi:10.1001/jamadermatol.2022.0655

This randomized clinical trial evaluates the effect of ixekizumab on self-reported and objective measures of case severity, itch, adverse events, and other outcomes in children with plaque psoriasis.

Brief Report

UV Exposure and the Risk of Keratinocyte Carcinoma in Skin of Color: A Systematic Review

Abstract Full Text
JAMA Dermatol. 2022;158(5):542-546. doi:10.1001/jamadermatol.2022.0263

This systematic review assesses and synthesizes the published data concerning the association between UV exposure and the risk of keratinocyte carcinoma in individuals with skin of color.

Evaluation of the Prevalence and Incidence of Pediatric Alopecia Areata Using Electronic Health Record Data

Abstract Full Text
JAMA Dermatol. 2022;158(5):547-551. doi:10.1001/jamadermatol.2022.0351

This cohort study examines the prevalence and incidence of alopecia areata in a pediatric population across time, age, sex, race and ethnicity, and geographic areas within the US.

Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors

Abstract Full Text
JAMA Dermatol. 2022;158(5):552-557. doi:10.1001/jamadermatol.2022.0354

This cohort and nested case-control study examines risk factors for developing bullous pemphigoid after patients receive immune checkpoint inhibitors.

Consensus Statement

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(5):561-572. doi:10.1001/jamadermatol.2022.0434

This consensus statement describes an effort to reach international consensus among psoriasis experts on a uniform dosing regimen for treatment with methotrexate in adult and pediatric patients with psoriasis.

Images in Dermatology

Black Hairy Tongue

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(5):573. doi:10.1001/jamadermatol.2021.5314

This case report describes a thick black coating toward the medial and proximal parts on the dorsal aspect of the tongue along with hin, elongated, black fibers that gave the appearance of a hairy surface.

Tinea Pseudoimbricata

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(5):574. doi:10.1001/jamadermatol.2022.0025

This case report describes multiple erythematous to hyperpigmented plaques comprising concentric rings with associated scale on the upper back.

JAMA Dermatology Clinicopathological Challenge

Excessive Wrinkling on the Dorsum of the Hands and Wrists

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(5):577-578. doi:10.1001/jamadermatol.2022.0374

A man in his 20s presented with thickening and swelling of hands, including symmetrical white and transparent papules, white keratosis, and excessive wrinkling after immersion in water, accompanied by burning pruritus for 3 years. What is your diagnosis?

Necrotic Plaques on the Ears of a Patient With COVID-19

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(5):579-580. doi:10.1001/jamadermatol.2022.0745

A man in his 40s with a history of factor VII deficiency hemophilia presented with respiratory failure secondary to COVID-19, and developed erythematous and edematous necrotic plaques of the bilateral ears 3 days after admission. What is your diagnosis?

Research Letter

Billing Patterns and Geographic Distribution of Dermatologist-Dermatopathologists in the US From 2013 to 2017

Abstract Full Text
JAMA Dermatol. 2022;158(5):581-583. doi:10.1001/jamadermatol.2022.0073

This cross-sectional study uses Medicare data to characterize billing patterns of dermatologist-dermatopathologists and their geographic distribution in the US from 2013 to 2017.

Usefulness of Noninvasive Management With the Gutter Method for Epidermal Growth Factor Receptor Inhibitor–Induced Paronychia, Pyogenic Granuloma–Like Lesion, and Ingrown Nail

Abstract Full Text
JAMA Dermatol. 2022;158(5):583-585. doi:10.1001/jamadermatol.2022.0725

This case series investigates the characteristics of epidermal growth factor receptor inhibitor–induced nail changes and usefulness of the gutter method.

Observation

Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil

Abstract Full Text
JAMA Dermatol. 2022;158(5):586-587. doi:10.1001/jamadermatol.2022.0154

This case report describes 2 patients with verruca plana who were successfully treated with calcipotriol and fluorouracil.

Treatment of Livedoid Vasculopathy With Baricitinib

Abstract Full Text
JAMA Dermatol. 2022;158(5):587-589. doi:10.1001/jamadermatol.2022.0241

This case report describes 3 patients with livedoid vasculopathy that was resistant to conventional therapy and responded positively to treatment with baricitinib.

Comment & Response

Image Consent and the Development of Image-Based Artificial Intelligence

Abstract Full Text
JAMA Dermatol. 2022;158(5):589. doi:10.1001/jamadermatol.2022.0689

Image Consent and the Development of Image-Based Artificial Intelligence—Reply

Abstract Full Text
JAMA Dermatol. 2022;158(5):590. doi:10.1001/jamadermatol.2022.0108
Correction

Error in Author Name

Abstract Full Text
free access
JAMA Dermatol. 2022;158(5):590. doi:10.1001/jamadermatol.2022.1302
Peer Reviewers List

JAMA Dermatology Peer Reviewers in 2021

Abstract Full Text
free access online only
JAMA Dermatol. 2022;158(5):e220194. doi:10.1001/jamadermatol.2022.0194
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2022;158(5):478. doi:10.1001/jamadermatol.2021.4204
×